Capellades J, Teixidor P, Villalba G, Hostalot C, Plans G, Armengol R, Medrano S, Estival A, Luque R, Gonzalez S, Gil-Gil M, Villa S, Sepulveda J, García-Mosquera J J, Balana C
Neuro-radiology Service, Hospital del Mar, 08003, Barcelona, Spain.
Neurosurgery Service, Hospital Universitari Germans Trias i Pujol, IGTP, 08916, Badalona, Spain.
Clin Transl Oncol. 2017 Jun;19(6):727-734. doi: 10.1007/s12094-016-1598-6. Epub 2016 Dec 22.
We assessed agreement among neurosurgeons on surgical approaches to individual glioblastoma patients and between their approach and those recommended by the topographical staging system described by Shinoda.
Five neurosurgeons were provided with pre-surgical MRIs of 76 patients. They selected the surgical approach [biopsy, partial resection, or gross total resection (GTR)] that they would recommend for each patient. They were blinded to each other's response and they were told that patients were younger than 50 years old and without symptoms. Three neuroradiologists classified each case according to the Shinoda staging system.
Biopsy was recommended in 35.5-82.9%, partial resection in 6.6-32.9%, and GTR in 3.9-31.6% of cases. Agreement among their responses was fair (global kappa = 0.28). Nineteen patients were classified as stage I, 14 as stage II, and 43 as stage III. Agreement between the neurosurgeons and the recommendations of the staging system was poor for stage I (kappa = 0.14) and stage II (kappa = 0.02) and fair for stage III patients (kappa = 0.29). An individual analysis revealed that in contrast to the Shinoda system, neurosurgeons took into account T2/FLAIR sequences and gave greater weight to the involvement of eloquent areas.
The surgical approach to glioblastoma is highly variable. A staging system could be used to examine the impact of extent of resection, monitor post-operative complications, and stratify patients in clinical trials. Our findings suggest that the Shinoda staging system could be improved by including T2/FLAIR sequences and a more adequate weighting of eloquent areas.
我们评估了神经外科医生对个别胶质母细胞瘤患者手术入路的一致性,以及他们的入路与筱田所描述的地形学分期系统所推荐的入路之间的一致性。
向五位神经外科医生提供了76例患者的术前磁共振成像(MRI)。他们选择了会为每位患者推荐的手术入路[活检、部分切除或全切除(GTR)]。他们对彼此的回答不知情,且被告知患者年龄小于50岁且无症状。三位神经放射科医生根据筱田分期系统对每个病例进行分类。
35.5%-82.9%的病例推荐活检,6.6%-32.9%的病例推荐部分切除,3.9%-31.6%的病例推荐全切除。他们回答之间的一致性一般(总体kappa系数=0.28)。19例患者被分类为I期,14例为II期,43例为III期。神经外科医生与分期系统推荐之间的一致性在I期(kappa系数=0.14)和II期(kappa系数=0.02)较差,在III期患者中一般(kappa系数=0.29)。个体分析显示,与筱田系统不同,神经外科医生考虑了T2/液体衰减反转恢复(FLAIR)序列,并更重视功能区的受累情况。
胶质母细胞瘤的手术入路差异很大。分期系统可用于研究切除范围的影响、监测术后并发症以及在临床试验中对患者进行分层。我们的研究结果表明,通过纳入T2/FLAIR序列和对功能区进行更适当的加权,筱田分期系统可以得到改进。